Norbert W. Bischofberger - 06 Jun 2025 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Issuer symbol
VIR
Transactions as of
06 Jun 2025
Net transactions value
$0
Form type
4
Filing time
06 Jun 2025, 20:26:07 UTC
Previous filing
02 Jun 2025
Next filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BISCHOFBERGER NORBERT W Director C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO /s/ Vanina de Verneuil, Attorney-In-Fact 06 Jun 2025 0001190273

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -10,667 -44% $0.000000 13,333 06 Jun 2025 Direct F1
transaction VIR Common Stock Other $0 +10,667 $0.000000 10,667 06 Jun 2025 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer without consideration for tax planning purposes.
F2 The shares are held in the name of Nextquest, LLC, of which the Reporting Person is a managing member.